| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Angiotensin1 7AVE0991Renin angiotensin systemAngiotensinIVAngiotensinIII| 1 | 2007 | Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments. | 
| + | - | nl | Cardiovasc Drug Rev 25(2):162-74 (2007) Trask AJ |
| 2 | 2006 | Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist. | 
| + | - | nl | Cardiovasc Drug Rev 24(3-4):239-46 (2006) Santos RA |
| 3 | 2007 | Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. | 
| + | - | nl | Vasc Health Risk Manag 3(1):125-37 (2007) Schindler C |
| 4 | 2007 | ACE2 of the heart: From angiotensin I to angiotensin (1-7). | 
| + | - | nl | Cardiovasc Res 73(3):463-9 (2007) Keidar S |
| 5 | 2002 | Angiotensin-(1-7): an active member of the renin-angiotensin system. | 
| + | - | nl | J Physiol Pharmacol 53(4 Pt 1):533-40 (2002) Kucharewicz I |
| 6 | 2005 | Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 289(6):H2281-90 (2005) Ferrario CM |
| 7 | 2001 | Pathways of angiotensin-(1-7) metabolism in the kidney. | 
| + | - | nl | Nephrol Dial Transplant 16 Suppl 1(-):22-6 (2001) |
| 8 | 2005 | Cardiovascular actions of angiotensin-(1-7). | 
| + | - | nl | Braz J Med Biol Res 38(4):499-507 (2005) Ferreira AJ |
| 9 | 2010 | New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system. | 
| + | - | nl | J Pharmacol Sci 113(4):289-91 (2010) |